RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
RNTX
19 hedge funds and large institutions have $3.21M invested in Rein Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 16 reducing their positions, and 15 closing their positions.
Holders
19
Holders Change
-14
Holders Change %
-42.42%
% of All Funds
0.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
1
Reduced
16
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$5K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$7.85K |